Compassionate Sciences Alternative Treatment Center said it has become the first New Jersey medical marijuana dispensary to receive final state approval to manufacture new medical cannabis products for registered patients.
The Bellmawr, New Jersey dispensary said pharmaceutical-grade products are made with cannabis extracts and include two topical forms and one oral form. The topical products will be available to patients within a week, while lozenges are scheduled to be available within a month.
“These products have been formulated to meet the state’s high standards of quality,” said Dr. Steven Patierno, a member of the medical board of advisors for PalliaTech Inc., which operates the dispensary, cultivation and manufacturing units for Compassionate Sciences. “For children and elderly patients, in particular, topical and oral forms of medical cannabis are a crucially needed alternative to inhaled medicines, which can be difficult to administer to those patients.”
To read the full article, click here.
For more business news, visit Philadelphia Business Journal.
